Cardiol Therapeutics Inc T.CRDL.W.A

Primary Symbol: T.CRDL Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > Cardiol mentioned in Investors Digest

<< Previous

Bullboard Posts

Next >>

Post by Jordan1159on May 05, 2021 9:06am

163 Views

Post# 33130869

Cardiol mentioned in Investors Digest

Someone posted on Twitter that Cardiol was mentioned in Investors Digest. That could bring the company some additional exposure here as there are a ton of subscribers to that website apparently. You have to pay to read it but there is an image on Twitter so I got the just of it. I like it a lot! The more people that hear about this company, the better! Check it out and Go crdl .

<< Previous

Bullboard Posts

Next >>

Nord Precious Metals reveals silver zone at Castle East